Clinical trial
Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma
NCT01711879 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma
- Lead sponsor
- University of Colorado, Denver
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- October 31, 2015
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neovascular glaucoma